Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Hironori Tsujimoto | Medicine and Dentistry | Best Researcher Award

Prof Dr Hironori Tsujimoto National Defense Medical College, Japan

Prof. Dr. Hironori Tsujimoto’s education, professional experience, and research publications, he is indeed a strong candidate for the Best Researcher Award. His research in upper-gastrointestinal surgery, oncology, and innovative therapeutic techniques demonstrates significant contributions to the field. Below is a breakdown of his qualifications:

Publiacation Profile

orcid

Educational Background and Professional Experience

Prof. Dr. Tsujimoto graduated from the National Defense Medical College in 1993, completed his residency, and advanced his career through post-doctoral studies at both National Defense Medical College and the University of Florida. Since 2007, he has held key positions, including Assistant Professor and Director of Upper-gastrointestinal Surgery, contributing extensively to both surgical practice and research.

Research Contributions

Prof. Tsujimoto has consistently focused on cancer research, especially in gastrointestinal malignancies, lymph node metastasis, and therapeutic innovations. His research output, including publications in top journals, underscores his influence in the field. Some highlights include the study on high mobility group box chromosomal protein 1 expression in esophageal squamous cell carcinoma, published in Journal of Gastroenterology and Hepatology (2020). This work showed how perioperative protein levels impact long-term outcomes in cancer patients, advancing clinical management practices.

Membership

Prof. Tsujimoto is an active member of several prestigious medical organizations in Japan. These include the Japanese Surgical Society, the Japanese Society of Gastroenterological Surgery, and the Japanese Society for Clinical Surgery. Dr. [Name] also contributes to the Japanese Society for Surgical Metabolism and Nutrition, the Japan Shock Society, and the Japan Society for Endoscopic Surgery. Through these memberships, they stay at the forefront of surgical innovation and patient care, enhancing their expertise and contributing to the medical community.

Research

From 1993 to 2000, I served as a Research Associate at the Department of Surgery I, National Defense Medical College, under the guidance of Professor Mochizuki H. Since 2000, I have continued as a Research Associate at the same institution, now working in the Department of Surgery alongside Professor Hase K., with additional supervision by Professor Seki S. from the Department of Immunology and Microbiology. My research spans over two decades, contributing to advancements in surgical and immunological fields.

Publication Top Notes

Significance of resected stomach measurements in postoperative delayed gastric emptying following laparoscopic pylorus‐preserving gastrectom

ASO Author Reflections: Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma

Pivotal role of myeloid‐derived suppressor cells in infection‐related tumor growth

Postoperative complications and impaired long‐term survival—Is this causation or association?

Bacterial Translocation in Gastrointestinal Cancers and Cancer Treatment

Conclusion

Prof. Dr. Hironori Tsujimoto’s contributions to surgical oncology and innovative cancer treatments underscore his suitability for the Best Researcher Award. His pioneering work on photodynamic therapy, novel surgical techniques, and understanding of cancer progression significantly advances gastrointestinal surgery and cancer care.

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. 🌟🔬📚

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. 📊🔬💊🌍

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus